Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AEterna Zentaris Inc (NASDAQ:AEZS)

0.1816
Delayed Data
As of Jul 31
 -0.0075 / -3.97%
Today’s Change
0.18
Today|||52-Week Range
1.54
-69.73%
Year-to-Date
No recent news for AEterna Zentaris Inc.

Today’s Trading

Previous close0.19
Today’s open0.18
Day’s range0.18 - 0.19
Volume2,843,822
Average volume (3 months)4,323,617
Market cap$23.5M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-221.74%
Earnings growth (this year)-12.07%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-99.82%
P/E ratio--
Price/Sales3,196.60
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
FSIFlexible Solutions I...-0.03-2.65%
SVONSevion Therapeutics ...-0.04-5.39%
BASIBioanalytical System...0.000.00%
OPGNOpGen Inc-0.06-1.77%
Data as of 3:57pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$11.0K
Annual profit (last year)-$16.6M
Net profit margin-156,245.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David A. Dodd
Chief Financial Officer &
Senior Vice President
Dennis Turpin
Corporate headquarters
Québec, Quebec

Forecasts